Ace Report Cover
TXA effective in reducing blood loss in mini-invasive TKA with postoperative rivaroxaban
Reprints
Cite This
Reprints
Cite This
AceReport Image
Arthroplasty
TXA effective in reducing blood loss in mini-invasive TKA with postoperative rivaroxaban
J Arthroplasty. 2017 Mar;32(3):801-806
Contributing Authors

PC Lin CC Huang JW Wang B Chen FC Kuo SH Yen

200 patients scheduled for minimally invasive total knee arthroplasty and thromboprophylaxis with rivaroxaban were randomized to either intravenous tranexamic acid or placebo. Patients were assessed for blood loss, transfusion rate, hemoglobin levels, rates of ecchymosis, wound hematoma, and deep infection. Total blood loss was significantly lower in the TXA group compared to placebo, while no significant difference was observed in postoperative drain volume. Transfusion rate was significantly lower in the TXA group compared to the placebo group, as were the incidences of ecchymosis and hematoma.

Unlock the full article

Get unlimited access to OrthoEvidence with a free trial
Start Trial

Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics

Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics

Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions

Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics

Or continue reading this full article
Register Now
AskOE
Search
Close Search Window
Welcome Back!
Forgot Password?
Create an Account

Account will be affiliated with


OR
Forgot Password?

OR
Check your email

If an account exists with the provided email address, a password reset email will be sent to you. If you don't see the email, please check your spam or junk folder.

For further assistance, contact our support team.

Cite this Ace Report

OrthoEvidence. TXA effective in reducing blood loss in mini-invasive TKA with postoperative rivaroxaban. ACE Report. 2017;7(11):17. Available from: https://myorthoevidence.com/AceReport/Report/txa-effective-in-reducing-blood-loss-in-mini-invasive-tka-with-postoperative-rivaroxaban

Copy Citation
Share this Ace Report